Fallopian tube removal shown to slash deadly ovarian cancer risk

New research confirms that most lethal ovarian cancers start in the fallopian tubes, and removing them during other surgeries can cut risk dramatically.

Recent findings reveal that nearly all deadly ovarian cancers actually begin in the fallopian tubes, shifting the focus of prevention strategies. Dr Rebecca Stone of Johns Hopkins Medicine highlighted that salpingectomy - the surgical removal of the tubes - when performed during an already planned abdominal operation can reduce the risk of tubo-ovarian cancer by at least 50 percent, with Canadian data indicating reductions as high as 80 percent.

Despite its effectiveness, the approach suffers from limited public knowledge and inconsistent insurance reimbursement, making it less common than tubal ligation. The added operative time is about eight minutes and recovery mirrors that of the primary surgery, making it a low-burden preventive measure. Stone noted that both average-risk women (1-2 % lifetime risk) and those with higher risk due to family history or BRCA1 mutations (5-40 % risk) could benefit.

If universally adopted, the practice could save nearly 2,000 lives annually in the United States and cut health-care spending by roughly half a billion dollars. More education and coverage are needed to make this option widely available.